+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Eyelid sebaceous carcinoma: a novel mutation in lymphoid enhancer-binding factor-1



Eyelid sebaceous carcinoma: a novel mutation in lymphoid enhancer-binding factor-1



British Journal of Dermatology 173(3): 811-814




(PDF emailed within 0-6 h: $19.90)

Accession: 057851631

Download citation: RISBibTeXText

PMID: 25639559

DOI: 10.1111/bjd.13706


Related references

Lymphoid enhancer factor-1 mediates loading of Pax3 to a promoter harbouring lymphoid enhancer factor-1 binding sites resulting in enhancement of transcription. International Journal of Biochemistry & Cell Biology 42(5): 630-640, 2010

Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1. Journal of Experimental & Clinical Cancer Research 28(): 58-58, 2009

Expression and proliferation-promoting role of lymphoid enhancer-binding factor 1 in human clear cell renal carcinoma. Cancer Investigation 32(7): 368-374, 2014

Morpheic plaque of the lower eyelid. Sebaceous carcinoma of the eyelid. Archives of Dermatology 123(5): 654-5, 658, 1987

Expression of the CCAAT/enhancer-binding protein transcription factor family in the sebaceous gland. Journal of Investigative Dermatology Symposium Proceedings 8(1): 135, June, 2003

Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-b and Wnt pathways. Proceedings of the National Academy of Sciences of the United States of America 97(15): 58-63, 2000

Lymphoid enhancer-binding factor-1 (LEF1) interacts with the DNA-binding domain of the vitamin D receptor. Journal of Biological Chemistry 286(21): 18444-18451, 2011

Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proceedings of the National Academy of Sciences of the United States of America 97(15): 8358-8363, 2000

Lymphoid enhancer binding factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia. Oncotarget 5(3): 649-658, 2015

Lymphoid Enhancer Factor-1 Links Two Hereditary Leukemia Syndromes through Core-binding Factor a Regulation of ELA2. The Journal of Biological Chemistry 279(4): 73-84, 2004

Lymphoid enhancer factor-1 links two hereditary leukemia syndromes through core-binding factor alpha regulation of ELA2. Journal of Biological Chemistry 279(4): 2873-2884, 2003

Smad4 cooperates with lymphoid enhancer-binding factor 1/T cell-specific factor to increase c-myc expression in the absence of TGF-b signaling. Proceedings of the National Academy of Sciences of the United States of America 103(49): 580-5, 2006

Overexpression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia. International Journal of Laboratory Hematology 37(5): 631-640, 2016

Lithium induces gene expression through lymphoid enhancer-binding factor/T-cell factor responsive element in rat PC12 cells. Neuroscience Letters 317(1): 50-52, January 4, 2002

Lithium induces gene expression through lymphoid enhancer-binding factor/T-cell factor responsive element in rat PC12 cells. Neuroscience Letters 317(1): 50-52, 2001